SCHEMBL915280

SCHEMBL915280

CCOP(=O)(O)Cc1ccc(N)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.46
HDAC1 Q13547 1/20 0.44
PPARD Q03181 1/20 0.42
PPIB P23284 1/20 0.42
PPIA P62937 1/20 0.42
PPID Q08752 1/20 0.42
PPIG Q13427 1/20 0.42
CYP3A4 P08684 2/20 0.42
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
MAOA P21397 1/20 0.42
TSHR P16473 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
POLB P06746 1/20 0.39
ANPEP P15144 1/20 0.39
ERAP2 Q6P179 1/20 0.39
ENPP2 Q13822 1/20 0.39
GFER P55789 1/20 0.37
ALDH1A1 P00352 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17488978 0.90 PPARD (0.50) HDAC1PPARDTSHRPOLBENPP2
SCHEMBL479061 0.83 CCNT1 (0.46) FDPSHDAC1PPARDPPIBPPIA
SCHEMBL914694 0.83 FDPS (0.47) FDPSPPIBPPIAPPIDPPIG
SCHEMBL915441 0.83 PPARD (0.44) HDAC1PPARDCYP3A4LMNAPOLB
SCHEMBL914541 0.83 PPARD (0.44) HDAC1PPARDLMNATSHRPOLB
SCHEMBL27866003 0.83 TSHR (0.56) FDPSPPIBPPIDPPIGMAOA
Hypochlorous Acid SCHEMBL3120213 0.82 CCNT1 (0.44) FDPSHDAC1PPARDPPIBPPIA
SCHEMBL12648165 0.81 PPARD (0.42) HDAC1PPARDCYP3A4POLBENPP2
SCHEMBL2029488 0.81 HDAC1 (0.43) FDPSHDAC1PPIBPPIAPPID
SCHEMBL914602 0.81 PPARD (0.42) HDAC1PPARDTDP1POLBENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3939964-A1 COMBINATIONS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS Ardelyx, Inc. (US) 2022-01-19 EP disclosed
US-7868126-B2 Process for producing polyester, polyester produced using said process, and polyester molded product TOYO BOSEKI KABUSHIKI KAISHA (JP) 2011-01-11 US disclosed
EP-1842868-B1 PROCESS FOR PRODUCING POLYESTER, POLYESTER PRODUCED USING SAID PROCESS, AND POLYESTER MOLDED PRODUCT TOYO BOSEKI (JP) 2010-11-10 EP disclosed
US-20090082529-A1 Polyester, Process for Producing Polyester, and Polyester Molded Article TOYO BOSEKI KABUSHIKI KAISHA (JP) 2009-03-26 US disclosed
US-20080249280-A1 Process for Producing Polyester, Polyester Produced Using Said Process, and Polyester Molded Product TOYO BOSEKI KABUSHIKI KAISHA (JP) 2008-10-09 US disclosed
EP-1932867-A1 POLYESTER, PROCESS FOR PRODUCTION OF POLYESTER, AND POLYESTER MOLDED ARTICLE Toyo Boseki Kabushiki Kasisha (JP) 2008-06-18 EP disclosed
EP-1842868-A1 PROCESS FOR PRODUCING POLYESTER, POLYESTER PRODUCED USING SAID PROCESS, AND POLYESTER MOLDED PRODUCT Toyo Boseki Kabushiki Kasisha (JP) 2007-10-10 EP disclosed